Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RESMETIROM vs REYATAZ: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RESMETIROM vs REYATAZ: Safety Overview

Metric RESMETIROM REYATAZ
Total FAERS Reports 881 142
Deaths Reported 26 12
Death Rate 3.0% 8.5%
Hospitalizations 50 50
Average Patient Age 58.1 yrs 44.8 yrs
% Female Patients 65.3% N/A
FDA Approval Date Mar 14, 2024 N/A
Manufacturer Madrigal Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A